Mauviel A, Loyau G, Pujol J P
Laboratoire de Biochimie du Tissu Conjonctif, CHU, Caen.
Rev Rhum Mal Osteoartic. 1991 Apr;58(4):241-5.
In this work, the authors have studied the effect of advocate/soya-bean extracts (Piasclédine) on the collagenolytic activity of cultured rabbit articular chondrocytes and human rheumatoid synovial cells. Incubation of these cells for 48 h with 10 micrograms/ml of Piasclédine show that this drug slightly increases collagenase production. As expected, incubation of these cells with interleukin-1 (100 pg/ml) induces an important release of collagenase. Piasclédine partially reverses the effect of interleukin-1 on synovial cells and totally abolishes its action on chondrocytes. Moreover, incubation of the two cell types for 5 days with Piasclédine prior to a 48 h-exposure to interleukin-1 prevents partially the effect of interleukin-1. These data suggest a potential role for Piasclédine to limit the deleterious effects of interleukin-1 in osteoarticular diseases by reducing the capacity of this cytokine to stimulate collagenase production by synoviocytes and chondrocytes.
在这项研究中,作者研究了骨碎补/大豆提取物(碧萝芷)对培养的兔关节软骨细胞和人类风湿性滑膜细胞胶原酶活性的影响。用10微克/毫升的碧萝芷孵育这些细胞48小时后发现,该药物会轻微增加胶原酶的产生。正如预期的那样,用白细胞介素-1(100皮克/毫升)孵育这些细胞会诱导胶原酶的大量释放。碧萝芷可部分逆转白细胞介素-1对滑膜细胞的作用,并完全消除其对软骨细胞的作用。此外,在暴露于白细胞介素-1的48小时之前,用碧萝芷孵育这两种细胞类型5天可部分预防白细胞介素-1的作用。这些数据表明,碧萝芷可能通过降低这种细胞因子刺激滑膜细胞和软骨细胞产生胶原酶的能力,来限制白细胞介素-1在骨关节疾病中的有害作用。